Skip to Main Content

Paper Details

Immunogenicity following revaccination or sequential vaccination with 23-valent pneumococcal polysaccharide vaccine (PPSV23) in older adults and those at increased risk of pneumococcal disease: a review of the literature.
Expert Rev Vaccines
10
2021

Datasets

Release 1.2